GlaxoSmithKline grants researchers access to clinical trial data
@article{Coombes2012GlaxoSmithKlineGR,
title={GlaxoSmithKline grants researchers access to clinical trial data},
author={R. Coombes},
journal={BMJ : British Medical Journal},
year={2012},
volume={345}
}GlaxoSmithKline has taken steps to open up more clinical data behind its drug trials, just months after the company was fined a record amount for ethical breaches.
From January all anonymised patient level data that sit hidden behind the results of clinical trials of its approved and failed drugs will be available without charge through a secure website once access has been approved.
Andrew Witty, GSK’s chief executive, said that the move sprang from a desire to dismiss the perception that… CONTINUE READING
Topics from this paper
12 Citations
GSK backs BMJ’s new policy to publish only studies with full access to data
- Medicine
- BMJ : British Medical Journal
- 2012
- 1
Timely publication and sharing of trial data: opportunities and challenges for comparative effectiveness research in cardiovascular disease.
- Medicine, Business
- European heart journal. Quality of care & clinical outcomes
- 2015
- 4
- PDF
Computational Drug Repositioning: From Data to Therapeutics
- Medicine
- Clinical pharmacology and therapeutics
- 2013
- 231